Review




Structured Review

Proteintech reca 1
Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Reca 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/RAD51+Fusion+Protein/pmc12972984-356-25-23
Average 94 stars, based on 3 article reviews
reca 1 - by Bioz Stars, 2026-09
94/100 stars

Images

1) Product Images from "Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia"

Article Title: Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

Journal: Bioactive Materials

doi: 10.1016/j.bioactmat.2026.03.009

Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker RECA-1. (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Figure Legend Snippet: Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker RECA-1. (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

Techniques Used: Staining, Activation Assay, Marker

Related Articles

Membrane:

Article Title: Palmitic Acid Induces Ferroptosis in Retinal Microvascular Endothelial Cells by Palmitoylation of Keap1 to Affect Diabetic Retinopathy
Article Snippet: Finally, the sections were photographed under an inverted microscope (Olympus BX63). .. The extracted proteins were transferred onto a nitrocellulose membrane and then incubated with the following primary antibodies: kelch-like ECH-associated protein 1 (Keap1; 1:2000, 60027-1-Ig; Proteintech, Rosemont, IL, USA), nuclear factor erythroid 2–related factor 2 (Nrf2; 1:1000, GB113808 ; Servicebio, Wuhan, China), glutathione peroxidase 4 (GPX4; 1:5000, 67763-1-Ig; Proteintech) and acyl-CoA synthetase long-chain family member 4 (ACSL4; 1:6000, 22401-1-AP; Proteintech). ..

Incubation:

Article Title: Palmitic Acid Induces Ferroptosis in Retinal Microvascular Endothelial Cells by Palmitoylation of Keap1 to Affect Diabetic Retinopathy
Article Snippet: Finally, the sections were photographed under an inverted microscope (Olympus BX63). .. The extracted proteins were transferred onto a nitrocellulose membrane and then incubated with the following primary antibodies: kelch-like ECH-associated protein 1 (Keap1; 1:2000, 60027-1-Ig; Proteintech, Rosemont, IL, USA), nuclear factor erythroid 2–related factor 2 (Nrf2; 1:1000, GB113808 ; Servicebio, Wuhan, China), glutathione peroxidase 4 (GPX4; 1:5000, 67763-1-Ig; Proteintech) and acyl-CoA synthetase long-chain family member 4 (ACSL4; 1:6000, 22401-1-AP; Proteintech). ..

Article Title: Dental Pulp Stem Cell-Derived Intracellular Vesicles Promote Cartilage Regeneration and Alleviate Pain in Temporomandibular Joint Osteoarthritis
Article Snippet: Identical protein loads (10 μg per lane) were resolved by SDS-PAGE and electro-transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, Germany). .. After blocking with 5 % skim milk, the membranes were incubated overnight at 4 °C with the following primary antibodies: anti-Aggrecan(ACAN) (ABclonal,A8536,1:1000, anti-Collagen type II alpha 1 chain(Col2a1) (Proteintech,28459-1-AP,1:1000), anti-Matrix Metallopeptidase 13(MMP13) (ABclonal,A11755,1:2000), anti-Matrix Metallopeptidase 3(MMP3) (Servicebio,GB11131,1:5000), anti-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Servicebio,GB11002,1:5000), anti-SRY-box transcription factor 9(SOX9) (Proteintech,67439-1-Ig,1:10000), anti-Neurofilament(NF-H) (ABclonal,A19084,1:2000), anti-Extracellular regulated protein kinases1/2(ERK1/2) (ABclonal,A4782,1:3000), anti-Phospho-ERK1/2(ABclonal,A90974,1:1000), anti-cAMP responsive element binding protein 1(CREB1) (Proteintech, 28792-1-AP, 1:5000), anti-Phospho-CREB1(Proteintech, 67927-1-Ig, 1:10000) and anti-Calcitonin-gene-related peptide(CGRP) (ABclonal,A5542,1:3000. .. Following the washes, membranes were probed for 1 h at room temperature with HRP-conjugated goat anti-rabbit or anti-mouse IgG secondary antibodies (Proteintech, 1:1000).

Blocking Assay:

Article Title: Dental Pulp Stem Cell-Derived Intracellular Vesicles Promote Cartilage Regeneration and Alleviate Pain in Temporomandibular Joint Osteoarthritis
Article Snippet: Identical protein loads (10 μg per lane) were resolved by SDS-PAGE and electro-transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, Germany). .. After blocking with 5 % skim milk, the membranes were incubated overnight at 4 °C with the following primary antibodies: anti-Aggrecan(ACAN) (ABclonal,A8536,1:1000, anti-Collagen type II alpha 1 chain(Col2a1) (Proteintech,28459-1-AP,1:1000), anti-Matrix Metallopeptidase 13(MMP13) (ABclonal,A11755,1:2000), anti-Matrix Metallopeptidase 3(MMP3) (Servicebio,GB11131,1:5000), anti-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Servicebio,GB11002,1:5000), anti-SRY-box transcription factor 9(SOX9) (Proteintech,67439-1-Ig,1:10000), anti-Neurofilament(NF-H) (ABclonal,A19084,1:2000), anti-Extracellular regulated protein kinases1/2(ERK1/2) (ABclonal,A4782,1:3000), anti-Phospho-ERK1/2(ABclonal,A90974,1:1000), anti-cAMP responsive element binding protein 1(CREB1) (Proteintech, 28792-1-AP, 1:5000), anti-Phospho-CREB1(Proteintech, 67927-1-Ig, 1:10000) and anti-Calcitonin-gene-related peptide(CGRP) (ABclonal,A5542,1:3000. .. Following the washes, membranes were probed for 1 h at room temperature with HRP-conjugated goat anti-rabbit or anti-mouse IgG secondary antibodies (Proteintech, 1:1000).

Binding Assay:

Article Title: Dental Pulp Stem Cell-Derived Intracellular Vesicles Promote Cartilage Regeneration and Alleviate Pain in Temporomandibular Joint Osteoarthritis
Article Snippet: Identical protein loads (10 μg per lane) were resolved by SDS-PAGE and electro-transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, Germany). .. After blocking with 5 % skim milk, the membranes were incubated overnight at 4 °C with the following primary antibodies: anti-Aggrecan(ACAN) (ABclonal,A8536,1:1000, anti-Collagen type II alpha 1 chain(Col2a1) (Proteintech,28459-1-AP,1:1000), anti-Matrix Metallopeptidase 13(MMP13) (ABclonal,A11755,1:2000), anti-Matrix Metallopeptidase 3(MMP3) (Servicebio,GB11131,1:5000), anti-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Servicebio,GB11002,1:5000), anti-SRY-box transcription factor 9(SOX9) (Proteintech,67439-1-Ig,1:10000), anti-Neurofilament(NF-H) (ABclonal,A19084,1:2000), anti-Extracellular regulated protein kinases1/2(ERK1/2) (ABclonal,A4782,1:3000), anti-Phospho-ERK1/2(ABclonal,A90974,1:1000), anti-cAMP responsive element binding protein 1(CREB1) (Proteintech, 28792-1-AP, 1:5000), anti-Phospho-CREB1(Proteintech, 67927-1-Ig, 1:10000) and anti-Calcitonin-gene-related peptide(CGRP) (ABclonal,A5542,1:3000. .. Following the washes, membranes were probed for 1 h at room temperature with HRP-conjugated goat anti-rabbit or anti-mouse IgG secondary antibodies (Proteintech, 1:1000).

Article Title: Identification of monomethylsulochrin as a novel agent to ameliorate DSS-induced ulcerative colitis through dual modulation of the IL-17/TNF pathway and gut microbiota.
Article Snippet: Novel therapeutic agents with improved safety and efficacy are urgently required for ulcerative colitis (UC), a refractory inflammatory bowel disease.. Mangrove-derived natural products represent a promising reservoir for drug discovery.. Monomethylsulochrin (MMSC) is a type II polyketide isolated from the endophytic fungus Aspergillus fumigatus of the mangrove plant Aegiceras corniculatum.

Article Title: Paeoniflorin Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Inhibiting Hepatic Lipogenesis and Inflammation
Article Snippet: Commercial kits for alanine transaminase (ALT, C009-2-1), aspartate transferase (AST, C010-2-1), total cholesterol (TC, A111-1-1), and triglyceride (TG, A110-1-1) were obtained from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). .. Antibodies for IL-17 A (26163-1-AP), fatty acid synthase (FASN, 10624-2-AP), sterol regulatory element binding protein 1 (SREBP1, 14088-1-AP), matrix metallopeptidase 13 (MMP13, 18165-1-AP), acetyl-CoA carboxylase 1 (ACC1, 21923-1-AP), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 60004-1-Ig) were obtained from Proteintech Group, Inc. (USA). ..

Activity Assay:

Article Title: CGRP/TSP1 Signaling Dampens Corneal Inflammation and Fibrosis by Targeting A2M During Corneal Stromal Wound Healing.
Article Snippet: .. Murine corneal sections and HTKs were fixed, permeabilized, and blocked as previously described.25 The following primary antibodies were used: TSP1 (18304-1-AP; Proteintech, Wuhan, China), A2M (MA5-38211; Thermo Fisher Scientific, Waltham, MA, USA), alpha-smooth muscle actin (α-SMA; ab5694; Abcam, Cambridge, UK), vimentin (60330- 1-Ig; Proteintech), APC/cyanine7-conjugated CD45 (103115; BioLegend, San Diego, CA, USA), FITC-conjugated CD45 (11-0451-85; Invitrogen, Carlsbad, CA, USA), receptor activity modifying protein 1 (RAMP1; 10327-1-AP; Proteintech), and calcitonin receptor-like receptor (CALCRL; E-AB-13173; Elabscience, Wuhan, China). ..

Article Title: CGRP/TSP1 Signaling Dampens Corneal Inflammation and Fibrosis by Targeting A2M During Corneal Stromal Wound Healing
Article Snippet: .. The following primary antibodies were used: TSP1 (18304-1-AP; Proteintech, Wuhan, China), A2M (MA5-38211; Thermo Fisher Scientific, Waltham, MA, USA), alpha-smooth muscle actin (α-SMA; ab5694; Abcam, Cambridge, UK), vimentin (60330-1-Ig; Proteintech), APC/cyanine7-conjugated CD45 (103115; BioLegend, San Diego, CA, USA), FITC-conjugated CD45 (11-0451-85; Invitrogen, Carlsbad, CA, USA), receptor activity modifying protein 1 (RAMP1; 10327-1-AP; Proteintech), and calcitonin receptor-like receptor (CALCRL; E-AB-13173; Elabscience, Wuhan, China). ..



Similar Products

99
MedChemExpress dynamin related protein 1 drp1 inhibitor mdivi 1
USP18 aggravates cardiac I/R injury through regulation of mitochondria and inhibition of mitophagy. a Electron microscopy image showing mitophagy in USP18-cKO mouse hearts ( n= 5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. b Protein levels of PINK1, Parkin, ubiquitinated proteins (Ub), P62, and LC3II in mitochondria from heart tissue in USP18-cKO and WT mice 24 h after I/R injury ( n =4). c Electron microscopy image showing mitophagy in USP18-overexpres (OV) mouse hearts ( n =5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. d Protein levels of PINK1, Parkin, Ub, P62, and LC3II proteins in mitochondria from the heart tissue of USP18-OV mice 24 h after I/R injury ( n =4). Color shift in mitophagy dye (red) and lysosomal dye (green) in NRVMs showing mitophagy in NRVMs with USP18 siRNA transfection ( e ) or Ad-USP18 infection ( f ) and the quantitative mitophagy index in each group ( n= 5). Scale bar=9 μm. Protein levels of PINK1, Parkin, Ub, P62, and LC3II in mitochondria from NRVMs transfected with USP18 siRNA ( g ) or infected with Ad-USP18 ( h ). ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001 ⁎⁎⁎⁎ P <0.0001. USP18. Ubiquitin-specific protease 18; I/R. Ischemia/reperfusion; WT. Wild-type; KO. Knockout; P62. Sequestosome 1; LC3. Microtubule-associated <t>protein</t> <t>1</t> light chain 3; VDAC. Voltage-dependent anion channel.
Dynamin Related Protein 1 Drp1 Inhibitor Mdivi 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/Mdivi-1/pmc13054580-59-5-15
Average 99 stars, based on 1 article reviews
dynamin related protein 1 drp1 inhibitor mdivi 1 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

96
Bio-Techne corporation recombinant human igf-i/igf-1 protein, cf
USP18 aggravates cardiac I/R injury through regulation of mitochondria and inhibition of mitophagy. a Electron microscopy image showing mitophagy in USP18-cKO mouse hearts ( n= 5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. b Protein levels of PINK1, Parkin, ubiquitinated proteins (Ub), P62, and LC3II in mitochondria from heart tissue in USP18-cKO and WT mice 24 h after I/R injury ( n =4). c Electron microscopy image showing mitophagy in USP18-overexpres (OV) mouse hearts ( n =5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. d Protein levels of PINK1, Parkin, Ub, P62, and LC3II proteins in mitochondria from the heart tissue of USP18-OV mice 24 h after I/R injury ( n =4). Color shift in mitophagy dye (red) and lysosomal dye (green) in NRVMs showing mitophagy in NRVMs with USP18 siRNA transfection ( e ) or Ad-USP18 infection ( f ) and the quantitative mitophagy index in each group ( n= 5). Scale bar=9 μm. Protein levels of PINK1, Parkin, Ub, P62, and LC3II in mitochondria from NRVMs transfected with USP18 siRNA ( g ) or infected with Ad-USP18 ( h ). ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001 ⁎⁎⁎⁎ P <0.0001. USP18. Ubiquitin-specific protease 18; I/R. Ischemia/reperfusion; WT. Wild-type; KO. Knockout; P62. Sequestosome 1; LC3. Microtubule-associated <t>protein</t> <t>1</t> light chain 3; VDAC. Voltage-dependent anion channel.
Recombinant Human Igf I/Igf 1 Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/Recombinant+Human+IGF-I%2FIGF-1+Protein%2C+CF/custom%40291-g1%4042497058
Average 96 stars, based on 1 article reviews
recombinant human igf-i/igf-1 protein, cf - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

95
Bio-Techne corporation recombinant human dkk-1 protein
USP18 aggravates cardiac I/R injury through regulation of mitochondria and inhibition of mitophagy. a Electron microscopy image showing mitophagy in USP18-cKO mouse hearts ( n= 5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. b Protein levels of PINK1, Parkin, ubiquitinated proteins (Ub), P62, and LC3II in mitochondria from heart tissue in USP18-cKO and WT mice 24 h after I/R injury ( n =4). c Electron microscopy image showing mitophagy in USP18-overexpres (OV) mouse hearts ( n =5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. d Protein levels of PINK1, Parkin, Ub, P62, and LC3II proteins in mitochondria from the heart tissue of USP18-OV mice 24 h after I/R injury ( n =4). Color shift in mitophagy dye (red) and lysosomal dye (green) in NRVMs showing mitophagy in NRVMs with USP18 siRNA transfection ( e ) or Ad-USP18 infection ( f ) and the quantitative mitophagy index in each group ( n= 5). Scale bar=9 μm. Protein levels of PINK1, Parkin, Ub, P62, and LC3II in mitochondria from NRVMs transfected with USP18 siRNA ( g ) or infected with Ad-USP18 ( h ). ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001 ⁎⁎⁎⁎ P <0.0001. USP18. Ubiquitin-specific protease 18; I/R. Ischemia/reperfusion; WT. Wild-type; KO. Knockout; P62. Sequestosome 1; LC3. Microtubule-associated <t>protein</t> <t>1</t> light chain 3; VDAC. Voltage-dependent anion channel.
Recombinant Human Dkk 1 Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/Recombinant+Human+Dkk-1+Protein/custom%405439-dk%4042497058
Average 95 stars, based on 1 article reviews
recombinant human dkk-1 protein - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

94
MedChemExpress human nectin1 protein
Nectin4 competitively attenuates gD and <t>Nectin1</t> interaction. ( A ) HEK293T cells were cotransfected with Flag-tagged Nectin1, Myc-empty vector or Myc-PRV-gD, and either full-length or mutant Nectin4 plasmid. Protein samples were lysed at 4°C and incubated with Myc-magnetic beads for 2 h. The Nectin1-PRV-gD interaction was assessed by Western blot. The interaction between Nectin1 and gD was evaluated under different doses of Nectin4 and its mutants. HEK293T cells were cotransfected with Flag-tagged Nectin1, Myc-tagged PRV-gD, and increasing amounts of full-length Nectin4 ( B ), V5-tagged IgV-deletion ( C ), or V5-tagged IgC2 deletion mutants ( D ). The RFP control vector was included as a negative control. Cell lysates were incubated with Myc-magnetic beads at 4°C for 2 h, and the Nectin1-gD interaction was analyzed by Western blot. ( E ) The Nectin1-gD interaction under increasing doses of Nectin4 was determined by SPR. The Nectin4 protein was injected at increasing concentrations onto a surface precoated with a saturated mixture of Nectin1 and PRV-gD proteins. The binding affinity between PRV-gD and Nectin1 was measured by monitoring changes in resonance units (RU) in response to Nectin4 binding.
Human Nectin1 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/Nectin-1%2C+Human/pmc13483241-200-2-8
Average 94 stars, based on 1 article reviews
human nectin1 protein - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Proteintech reca 1
Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Reca 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/RAD51+Fusion+Protein/pmc12972984-356-25-23
Average 94 stars, based on 1 article reviews
reca 1 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
R&D Systems recombinant human vegfr1 flt 1 fc chimera protein
Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Recombinant Human Vegfr1 Flt 1 Fc Chimera Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/Recombinant+Human+VEGFR1%2FFlt-1+Fc+Chimera+Protein/pmc13059125-197-3-9
Average 94 stars, based on 1 article reviews
recombinant human vegfr1 flt 1 fc chimera protein - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

97
Bio-Techne corporation recombinant human il-1 beta/il-1f2 protein
Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Recombinant Human Il 1 Beta/Il 1f2 Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/Recombinant+Human+IL-1+beta%2FIL-1F2+Protein/custom%40201-lb%4010%2E1177%2F23259671261463932
Average 97 stars, based on 1 article reviews
recombinant human il-1 beta/il-1f2 protein - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

94
MedChemExpress recombinant mouse igfbp1 protein
Integrated transcriptomic and network toxicology analyses identify potential molecular targets of FU against Pb-induced liver injury. ( A ) MA plots showing differentially expressed genes in the comparisons of Model versus Control and FU-H versus Model; ( B ) Venn diagram showing the overlap of differentially expressed genes between the Model versus Control and FU-H versus Model comparisons. A total of 111 common differentially expressed genes were identified; ( C ) KEGG pathway enrichment analysis of the overlapping differentially expressed genes. Bubble size represents the number of enriched genes, and bubble color represents the adjusted p value; ( D ) Venn diagram showing the intersection between Pb-related targets and liver injury-associated targets identified by network toxicology analysis; ( E ) GO enrichment circular plot of the intersecting targets, including biological process, cellular component, and molecular function categories; ( F ) GO Biological Process network illustrating the relationships between enriched biological processes and their associated genes; ( G ) KEGG pathway enrichment analysis of the intersecting targets obtained from network toxicology analysis; ( H ) heatmap showing the expression profiles of MAPK signaling pathway-related differentially expressed genes among the Control, Model, and FU-H groups. <t>IGFBP1</t> was identified as the most prominently altered candidate gene associated with FU-mediated protection. Differentially expressed genes were screened using the criteria of |log 2 fold change| ≥ 1 and adjusted p < 0.05. Enrichment analyses were performed based on significantly enriched GO terms and KEGG pathways.
Recombinant Mouse Igfbp1 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/IGFBP-1%2C+Mouse/pmc13413114-186-5-18
Average 94 stars, based on 1 article reviews
recombinant mouse igfbp1 protein - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
MedChemExpress recombinant human ampkα2β1γ1 heterotrimer protein
Integrated transcriptomic and network toxicology analyses identify potential molecular targets of FU against Pb-induced liver injury. ( A ) MA plots showing differentially expressed genes in the comparisons of Model versus Control and FU-H versus Model; ( B ) Venn diagram showing the overlap of differentially expressed genes between the Model versus Control and FU-H versus Model comparisons. A total of 111 common differentially expressed genes were identified; ( C ) KEGG pathway enrichment analysis of the overlapping differentially expressed genes. Bubble size represents the number of enriched genes, and bubble color represents the adjusted p value; ( D ) Venn diagram showing the intersection between Pb-related targets and liver injury-associated targets identified by network toxicology analysis; ( E ) GO enrichment circular plot of the intersecting targets, including biological process, cellular component, and molecular function categories; ( F ) GO Biological Process network illustrating the relationships between enriched biological processes and their associated genes; ( G ) KEGG pathway enrichment analysis of the intersecting targets obtained from network toxicology analysis; ( H ) heatmap showing the expression profiles of MAPK signaling pathway-related differentially expressed genes among the Control, Model, and FU-H groups. <t>IGFBP1</t> was identified as the most prominently altered candidate gene associated with FU-mediated protection. Differentially expressed genes were screened using the criteria of |log 2 fold change| ≥ 1 and adjusted p < 0.05. Enrichment analyses were performed based on significantly enriched GO terms and KEGG pathways.
Recombinant Human Ampkα2β1γ1 Heterotrimer Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/AMPK+gamma+1%2Fbeta+1%2Falpha+2+Heterotrimer%2C+Human/10__1016_slash_j__redox__2026__104314-55-1-9
Average 94 stars, based on 1 article reviews
recombinant human ampkα2β1γ1 heterotrimer protein - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
Proteintech zo 1
Gel-AgNA/MgGA MN promote mucosal regeneration. (a) HE and Safranin O staining of rabbit tracheal samples harvested at Day 10 post-operation after treated with Gel, Gel-AgNA, Gel-MgGA, and Gel-AgNA/MgGA MN. (b) IF staining of CK14 (marker of basal cells, red) and AC-Tub (marker of cilia cell, green). (c) IF staining <t>of</t> <t>ZO-1</t> (marker of tight junctions, orange). (d, e) Quantitative analysis of regenerated epithelial coverage and thickness (n = 9). (f) Masson and Sirius Red staining for collagen evaluation after various treatments (n = 5). Quantitative analysis of collagen volume fraction (g) and fiber orientation (h) . The pentagram indicates luminal side of trachea.
Zo 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+1/ZO1+Fusion+Protein/pmc12927103-197-9-10
Average 96 stars, based on 1 article reviews
zo 1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


USP18 aggravates cardiac I/R injury through regulation of mitochondria and inhibition of mitophagy. a Electron microscopy image showing mitophagy in USP18-cKO mouse hearts ( n= 5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. b Protein levels of PINK1, Parkin, ubiquitinated proteins (Ub), P62, and LC3II in mitochondria from heart tissue in USP18-cKO and WT mice 24 h after I/R injury ( n =4). c Electron microscopy image showing mitophagy in USP18-overexpres (OV) mouse hearts ( n =5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. d Protein levels of PINK1, Parkin, Ub, P62, and LC3II proteins in mitochondria from the heart tissue of USP18-OV mice 24 h after I/R injury ( n =4). Color shift in mitophagy dye (red) and lysosomal dye (green) in NRVMs showing mitophagy in NRVMs with USP18 siRNA transfection ( e ) or Ad-USP18 infection ( f ) and the quantitative mitophagy index in each group ( n= 5). Scale bar=9 μm. Protein levels of PINK1, Parkin, Ub, P62, and LC3II in mitochondria from NRVMs transfected with USP18 siRNA ( g ) or infected with Ad-USP18 ( h ). ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001 ⁎⁎⁎⁎ P <0.0001. USP18. Ubiquitin-specific protease 18; I/R. Ischemia/reperfusion; WT. Wild-type; KO. Knockout; P62. Sequestosome 1; LC3. Microtubule-associated protein 1 light chain 3; VDAC. Voltage-dependent anion channel.

Journal: Military Medical Research

Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L

doi: 10.1016/j.mmr.2026.100004

Figure Lengend Snippet: USP18 aggravates cardiac I/R injury through regulation of mitochondria and inhibition of mitophagy. a Electron microscopy image showing mitophagy in USP18-cKO mouse hearts ( n= 5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. b Protein levels of PINK1, Parkin, ubiquitinated proteins (Ub), P62, and LC3II in mitochondria from heart tissue in USP18-cKO and WT mice 24 h after I/R injury ( n =4). c Electron microscopy image showing mitophagy in USP18-overexpres (OV) mouse hearts ( n =5). Scale bar=3 μm. White arrowheads indicate sites of mitophagy. d Protein levels of PINK1, Parkin, Ub, P62, and LC3II proteins in mitochondria from the heart tissue of USP18-OV mice 24 h after I/R injury ( n =4). Color shift in mitophagy dye (red) and lysosomal dye (green) in NRVMs showing mitophagy in NRVMs with USP18 siRNA transfection ( e ) or Ad-USP18 infection ( f ) and the quantitative mitophagy index in each group ( n= 5). Scale bar=9 μm. Protein levels of PINK1, Parkin, Ub, P62, and LC3II in mitochondria from NRVMs transfected with USP18 siRNA ( g ) or infected with Ad-USP18 ( h ). ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001 ⁎⁎⁎⁎ P <0.0001. USP18. Ubiquitin-specific protease 18; I/R. Ischemia/reperfusion; WT. Wild-type; KO. Knockout; P62. Sequestosome 1; LC3. Microtubule-associated protein 1 light chain 3; VDAC. Voltage-dependent anion channel.

Article Snippet: To block mitophagy, the selective dynamin-related protein 1 (Drp1) inhibitor Mdivi-1 was used (50 μmol/L, MedChemExpress, USA).

Techniques: Inhibition, Electron Microscopy, Transfection, Infection, Ubiquitin Proteomics, Knock-Out

Nectin4 competitively attenuates gD and Nectin1 interaction. ( A ) HEK293T cells were cotransfected with Flag-tagged Nectin1, Myc-empty vector or Myc-PRV-gD, and either full-length or mutant Nectin4 plasmid. Protein samples were lysed at 4°C and incubated with Myc-magnetic beads for 2 h. The Nectin1-PRV-gD interaction was assessed by Western blot. The interaction between Nectin1 and gD was evaluated under different doses of Nectin4 and its mutants. HEK293T cells were cotransfected with Flag-tagged Nectin1, Myc-tagged PRV-gD, and increasing amounts of full-length Nectin4 ( B ), V5-tagged IgV-deletion ( C ), or V5-tagged IgC2 deletion mutants ( D ). The RFP control vector was included as a negative control. Cell lysates were incubated with Myc-magnetic beads at 4°C for 2 h, and the Nectin1-gD interaction was analyzed by Western blot. ( E ) The Nectin1-gD interaction under increasing doses of Nectin4 was determined by SPR. The Nectin4 protein was injected at increasing concentrations onto a surface precoated with a saturated mixture of Nectin1 and PRV-gD proteins. The binding affinity between PRV-gD and Nectin1 was measured by monitoring changes in resonance units (RU) in response to Nectin4 binding.

Journal: Journal of Virology

Article Title: Nectin4 restricts pseudorabies virus infection by blocking gD-Nectin1 interaction

doi: 10.1128/jvi.00788-26

Figure Lengend Snippet: Nectin4 competitively attenuates gD and Nectin1 interaction. ( A ) HEK293T cells were cotransfected with Flag-tagged Nectin1, Myc-empty vector or Myc-PRV-gD, and either full-length or mutant Nectin4 plasmid. Protein samples were lysed at 4°C and incubated with Myc-magnetic beads for 2 h. The Nectin1-PRV-gD interaction was assessed by Western blot. The interaction between Nectin1 and gD was evaluated under different doses of Nectin4 and its mutants. HEK293T cells were cotransfected with Flag-tagged Nectin1, Myc-tagged PRV-gD, and increasing amounts of full-length Nectin4 ( B ), V5-tagged IgV-deletion ( C ), or V5-tagged IgC2 deletion mutants ( D ). The RFP control vector was included as a negative control. Cell lysates were incubated with Myc-magnetic beads at 4°C for 2 h, and the Nectin1-gD interaction was analyzed by Western blot. ( E ) The Nectin1-gD interaction under increasing doses of Nectin4 was determined by SPR. The Nectin4 protein was injected at increasing concentrations onto a surface precoated with a saturated mixture of Nectin1 and PRV-gD proteins. The binding affinity between PRV-gD and Nectin1 was measured by monitoring changes in resonance units (RU) in response to Nectin4 binding.

Article Snippet: The purified human Nectin1 protein was purchased from MedChemExpress (HY- P70494 ).

Techniques: Plasmid Preparation, Mutagenesis, Incubation, Magnetic Beads, Western Blot, Control, Negative Control, Injection, Binding Assay

Schematic illustrating the mechanism by which Nectin4 restricts pseudorabies virus infection through blocking gD-Nectin1 interaction. PRV infection involves multiple steps, including attachment, internalization, membrane fusion, and genome release. Initial attachment is primarily mediated through interactions of viral glycoprotein gC with cell-surface heparan sulfate proteoglycans. Receptor binding by gD initiates the fusion cascade and viral internalization. Upon PRV infection, the interferon signaling pathway is activated (left), subsequently upregulating the expression of interferon-stimulated gene Nectin4 in neighboring cells. Nectin4 is located on the cell membrane and binds to gD through its IgV domain, preventing viral internalization (right). Figure created with BioRender (biorender.com).

Journal: Journal of Virology

Article Title: Nectin4 restricts pseudorabies virus infection by blocking gD-Nectin1 interaction

doi: 10.1128/jvi.00788-26

Figure Lengend Snippet: Schematic illustrating the mechanism by which Nectin4 restricts pseudorabies virus infection through blocking gD-Nectin1 interaction. PRV infection involves multiple steps, including attachment, internalization, membrane fusion, and genome release. Initial attachment is primarily mediated through interactions of viral glycoprotein gC with cell-surface heparan sulfate proteoglycans. Receptor binding by gD initiates the fusion cascade and viral internalization. Upon PRV infection, the interferon signaling pathway is activated (left), subsequently upregulating the expression of interferon-stimulated gene Nectin4 in neighboring cells. Nectin4 is located on the cell membrane and binds to gD through its IgV domain, preventing viral internalization (right). Figure created with BioRender (biorender.com).

Article Snippet: The purified human Nectin1 protein was purchased from MedChemExpress (HY- P70494 ).

Techniques: Virus, Infection, Blocking Assay, Membrane, Binding Assay, Expressing

Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker RECA-1. (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

Journal: Bioactive Materials

Article Title: Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

doi: 10.1016/j.bioactmat.2026.03.009

Figure Lengend Snippet: Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker RECA-1. (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

Article Snippet: The following primary antibodies were used for the subsequent steps: anti-Yap (mouse, 1:200, Santa sc-376830); anti-p-VEGFR2 (rabbit, 1:100 Invitrogen, PA5-105765); α-SMA (rabbit, 1:200, Proteintech 14395-1-AP); Reca-1 (mouse, 1:200, Santa sc-52665); anti-CD31 (mouse, 1:200, Santa sc-13537); anti-Ki67 (rabbit, 1:150, Cell Signaling 9129S); anti-NF-200 (mouse, 1:200, Sigma, SAB4200747); anti-MBP (rabbit, 1:200, Abcam ab218011); anti-F4/80 (mouse, 1:200, Santa sc-377009); Iba-1 (rabbit, 1:150, Abcam ab178846); anti-CGRP (rabbit, 1:400, Abcam ab283568); anti-TRPA1 (mouse, 1:200, Santa sc-376495); anti-CD86 (rabbit, 1:200, Proteintech 30691-1-AP); CD206 (rabbit, 1:200, Proteintech 18704-1-AP).

Techniques: Staining, Activation Assay, Marker

Integrated transcriptomic and network toxicology analyses identify potential molecular targets of FU against Pb-induced liver injury. ( A ) MA plots showing differentially expressed genes in the comparisons of Model versus Control and FU-H versus Model; ( B ) Venn diagram showing the overlap of differentially expressed genes between the Model versus Control and FU-H versus Model comparisons. A total of 111 common differentially expressed genes were identified; ( C ) KEGG pathway enrichment analysis of the overlapping differentially expressed genes. Bubble size represents the number of enriched genes, and bubble color represents the adjusted p value; ( D ) Venn diagram showing the intersection between Pb-related targets and liver injury-associated targets identified by network toxicology analysis; ( E ) GO enrichment circular plot of the intersecting targets, including biological process, cellular component, and molecular function categories; ( F ) GO Biological Process network illustrating the relationships between enriched biological processes and their associated genes; ( G ) KEGG pathway enrichment analysis of the intersecting targets obtained from network toxicology analysis; ( H ) heatmap showing the expression profiles of MAPK signaling pathway-related differentially expressed genes among the Control, Model, and FU-H groups. IGFBP1 was identified as the most prominently altered candidate gene associated with FU-mediated protection. Differentially expressed genes were screened using the criteria of |log 2 fold change| ≥ 1 and adjusted p < 0.05. Enrichment analyses were performed based on significantly enriched GO terms and KEGG pathways.

Journal: Marine Drugs

Article Title: Fucoidan Attenuates Lead-Induced Liver Injury Associated with IGFBP1 and Gut Microbiota-Derived Tryptophol Metabolism

doi: 10.3390/md24070232

Figure Lengend Snippet: Integrated transcriptomic and network toxicology analyses identify potential molecular targets of FU against Pb-induced liver injury. ( A ) MA plots showing differentially expressed genes in the comparisons of Model versus Control and FU-H versus Model; ( B ) Venn diagram showing the overlap of differentially expressed genes between the Model versus Control and FU-H versus Model comparisons. A total of 111 common differentially expressed genes were identified; ( C ) KEGG pathway enrichment analysis of the overlapping differentially expressed genes. Bubble size represents the number of enriched genes, and bubble color represents the adjusted p value; ( D ) Venn diagram showing the intersection between Pb-related targets and liver injury-associated targets identified by network toxicology analysis; ( E ) GO enrichment circular plot of the intersecting targets, including biological process, cellular component, and molecular function categories; ( F ) GO Biological Process network illustrating the relationships between enriched biological processes and their associated genes; ( G ) KEGG pathway enrichment analysis of the intersecting targets obtained from network toxicology analysis; ( H ) heatmap showing the expression profiles of MAPK signaling pathway-related differentially expressed genes among the Control, Model, and FU-H groups. IGFBP1 was identified as the most prominently altered candidate gene associated with FU-mediated protection. Differentially expressed genes were screened using the criteria of |log 2 fold change| ≥ 1 and adjusted p < 0.05. Enrichment analyses were performed based on significantly enriched GO terms and KEGG pathways.

Article Snippet: Sodium carboxymethyl cellulose (CMC-Na, HY-Y1889A), recombinant mouse IGFBP1 protein (HY-P700256), and tryptophol (TOL, HY-W010155) were also purchased from MedChemExpress (MCE; Monmouth Junction, NJ, USA).

Techniques: Control, Expressing

Experimental validation of potential molecular targets involved in FU-mediated protection against Pb-induced liver injury. ( A ) RT-qPCR validation of representative intersecting genes identified by integrated transcriptomic and network toxicology analyses, including Igfbp1 , Ppp1r10 , Dnajb9 , Hspa1a , Cyp2a4 , Cbx2 , Gadd45a , and Egr1 , in the Control, Model, and FU-H groups; ( B – E ) RT-qPCR analysis of MAPK signaling pathway-related genes, including Map2k1 ( B ), Map2k2 ( C ), Mapk1 ( D ), and Mapk3 ( E ). Data are presented as mean ± SD, n = 6 per group. Statistical significance was determined by one-way ANOVA. Compared with the Model group: *** p < 0.001, and **** p < 0.0001.

Journal: Marine Drugs

Article Title: Fucoidan Attenuates Lead-Induced Liver Injury Associated with IGFBP1 and Gut Microbiota-Derived Tryptophol Metabolism

doi: 10.3390/md24070232

Figure Lengend Snippet: Experimental validation of potential molecular targets involved in FU-mediated protection against Pb-induced liver injury. ( A ) RT-qPCR validation of representative intersecting genes identified by integrated transcriptomic and network toxicology analyses, including Igfbp1 , Ppp1r10 , Dnajb9 , Hspa1a , Cyp2a4 , Cbx2 , Gadd45a , and Egr1 , in the Control, Model, and FU-H groups; ( B – E ) RT-qPCR analysis of MAPK signaling pathway-related genes, including Map2k1 ( B ), Map2k2 ( C ), Mapk1 ( D ), and Mapk3 ( E ). Data are presented as mean ± SD, n = 6 per group. Statistical significance was determined by one-way ANOVA. Compared with the Model group: *** p < 0.001, and **** p < 0.0001.

Article Snippet: Sodium carboxymethyl cellulose (CMC-Na, HY-Y1889A), recombinant mouse IGFBP1 protein (HY-P700256), and tryptophol (TOL, HY-W010155) were also purchased from MedChemExpress (MCE; Monmouth Junction, NJ, USA).

Techniques: Biomarker Discovery, Quantitative RT-PCR, Control

IGFBP1 is associated with FU-mediated protection against Pb-induced liver injury. ( A ) Schematic illustration of the experimental design for IGFBP1 rescue experiments; ( B ) serum IGFBP1 levels in the Model, FU-H, and IGFBP1+FU-H groups; ( C ) body weight of mice at the end of the experiment; ( D ) liver organ weight index; ( E ) representative H&E-stained liver sections from the Model, FU-H, and IGFBP1+FU-H groups. The upper panels show 100×-magnification images (scale bar = 200 μm), and the lower panels show enlarged views of the dashed areas (scale bar = 100 μm). Red arrows indicate inflammatory cell infiltration, and green arrows indicate fatty vacuolation; ( F ) Histology scores of liver sections. ( G – I ) Serum levels of hepatic injury biomarkers, including ALT ( G ), AST ( H ), and ALP ( I ); ( J – L ) serum oxidative stress-related indicators, including SOD activity ( J ), GSH level ( K ), and MDA level ( L ); ( M – O ) hepatic oxidative stress-related indicators, including SOD activity ( M ), GSH level ( N ), and MDA level ( O ). ( P – R ) Serum levels of pro-inflammatory cytokines, including IL-6 ( P ), TNF-α ( Q ), and IL-1β ( R ); Data are presented as mean ± SD, n = 6 per group. Statistical significance was determined by one-way ANOVA. Compared with the FU-H group: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Journal: Marine Drugs

Article Title: Fucoidan Attenuates Lead-Induced Liver Injury Associated with IGFBP1 and Gut Microbiota-Derived Tryptophol Metabolism

doi: 10.3390/md24070232

Figure Lengend Snippet: IGFBP1 is associated with FU-mediated protection against Pb-induced liver injury. ( A ) Schematic illustration of the experimental design for IGFBP1 rescue experiments; ( B ) serum IGFBP1 levels in the Model, FU-H, and IGFBP1+FU-H groups; ( C ) body weight of mice at the end of the experiment; ( D ) liver organ weight index; ( E ) representative H&E-stained liver sections from the Model, FU-H, and IGFBP1+FU-H groups. The upper panels show 100×-magnification images (scale bar = 200 μm), and the lower panels show enlarged views of the dashed areas (scale bar = 100 μm). Red arrows indicate inflammatory cell infiltration, and green arrows indicate fatty vacuolation; ( F ) Histology scores of liver sections. ( G – I ) Serum levels of hepatic injury biomarkers, including ALT ( G ), AST ( H ), and ALP ( I ); ( J – L ) serum oxidative stress-related indicators, including SOD activity ( J ), GSH level ( K ), and MDA level ( L ); ( M – O ) hepatic oxidative stress-related indicators, including SOD activity ( M ), GSH level ( N ), and MDA level ( O ). ( P – R ) Serum levels of pro-inflammatory cytokines, including IL-6 ( P ), TNF-α ( Q ), and IL-1β ( R ); Data are presented as mean ± SD, n = 6 per group. Statistical significance was determined by one-way ANOVA. Compared with the FU-H group: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Article Snippet: Sodium carboxymethyl cellulose (CMC-Na, HY-Y1889A), recombinant mouse IGFBP1 protein (HY-P700256), and tryptophol (TOL, HY-W010155) were also purchased from MedChemExpress (MCE; Monmouth Junction, NJ, USA).

Techniques: Staining, Activity Assay

Schematic illustration of the potential mechanisms associated with FU-mediated attenuation of Pb-induced liver injury. Pb exposure disrupts gut microbiota homeostasis, induces microbial dysbiosis, and increases systemic Pb burden, thereby contributing to hepatic oxidative stress, inflammatory responses, and liver injury. FU treatment decreased Pb levels in serum and liver and increased fecal Pb content. In the intestine, FU treatment was associated with remodeling of Pb-disrupted gut microbiota, including increased relative abundance of beneficial bacteria such as Akkermansia muciniphila and Bifidobacterium pseudolongum, as well as alterations in fecal tryptophan metabolism, particularly tryptophol (TOL). Through the gut–liver axis, these FU-associated intestinal changes may contribute to the alleviation of Pb-induced hepatic injury. In the liver, FU protection was associated with IGFBP1-related redox modulation, increased antioxidant capacity, including SOD activity and GSH content, reduced lipid peroxidation, as reflected by decreased MDA levels and suppressed inflammatory responses, including TNF-α, IL-1β, and IL-6. These coordinated changes were accompanied by reduced serum ALT, AST, and ALP levels, alleviated hepatic pathological lesions, and improved hepatic homeostasis.

Journal: Marine Drugs

Article Title: Fucoidan Attenuates Lead-Induced Liver Injury Associated with IGFBP1 and Gut Microbiota-Derived Tryptophol Metabolism

doi: 10.3390/md24070232

Figure Lengend Snippet: Schematic illustration of the potential mechanisms associated with FU-mediated attenuation of Pb-induced liver injury. Pb exposure disrupts gut microbiota homeostasis, induces microbial dysbiosis, and increases systemic Pb burden, thereby contributing to hepatic oxidative stress, inflammatory responses, and liver injury. FU treatment decreased Pb levels in serum and liver and increased fecal Pb content. In the intestine, FU treatment was associated with remodeling of Pb-disrupted gut microbiota, including increased relative abundance of beneficial bacteria such as Akkermansia muciniphila and Bifidobacterium pseudolongum, as well as alterations in fecal tryptophan metabolism, particularly tryptophol (TOL). Through the gut–liver axis, these FU-associated intestinal changes may contribute to the alleviation of Pb-induced hepatic injury. In the liver, FU protection was associated with IGFBP1-related redox modulation, increased antioxidant capacity, including SOD activity and GSH content, reduced lipid peroxidation, as reflected by decreased MDA levels and suppressed inflammatory responses, including TNF-α, IL-1β, and IL-6. These coordinated changes were accompanied by reduced serum ALT, AST, and ALP levels, alleviated hepatic pathological lesions, and improved hepatic homeostasis.

Article Snippet: Sodium carboxymethyl cellulose (CMC-Na, HY-Y1889A), recombinant mouse IGFBP1 protein (HY-P700256), and tryptophol (TOL, HY-W010155) were also purchased from MedChemExpress (MCE; Monmouth Junction, NJ, USA).

Techniques: Bacteria, Activity Assay

Gel-AgNA/MgGA MN promote mucosal regeneration. (a) HE and Safranin O staining of rabbit tracheal samples harvested at Day 10 post-operation after treated with Gel, Gel-AgNA, Gel-MgGA, and Gel-AgNA/MgGA MN. (b) IF staining of CK14 (marker of basal cells, red) and AC-Tub (marker of cilia cell, green). (c) IF staining of ZO-1 (marker of tight junctions, orange). (d, e) Quantitative analysis of regenerated epithelial coverage and thickness (n = 9). (f) Masson and Sirius Red staining for collagen evaluation after various treatments (n = 5). Quantitative analysis of collagen volume fraction (g) and fiber orientation (h) . The pentagram indicates luminal side of trachea.

Journal: Bioactive Materials

Article Title: Spatiotemporally engineered microneedle for microenvironment remodeling propels mucosal regeneration after tracheal mucosal injury

doi: 10.1016/j.bioactmat.2026.01.026

Figure Lengend Snippet: Gel-AgNA/MgGA MN promote mucosal regeneration. (a) HE and Safranin O staining of rabbit tracheal samples harvested at Day 10 post-operation after treated with Gel, Gel-AgNA, Gel-MgGA, and Gel-AgNA/MgGA MN. (b) IF staining of CK14 (marker of basal cells, red) and AC-Tub (marker of cilia cell, green). (c) IF staining of ZO-1 (marker of tight junctions, orange). (d, e) Quantitative analysis of regenerated epithelial coverage and thickness (n = 9). (f) Masson and Sirius Red staining for collagen evaluation after various treatments (n = 5). Quantitative analysis of collagen volume fraction (g) and fiber orientation (h) . The pentagram indicates luminal side of trachea.

Article Snippet: Immunofluorescence staining of CK14 (Abcam, ab181595), AC-Tub (Proteintech, 66200-1-Ig), ZO-1 (Proteintech, 21773-1-AP), and Immunohistochemical (IHC) staining for CD31 (Servicebio, S1002) were conducted to reveal the conditions of mucosal regeneration, according to previous literature [ ].

Techniques: Staining, Marker